X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (75) 75
Journal Article (68) 68
Magazine Article (4) 4
Conference Proceeding (3) 3
Book Chapter (1) 1
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (25) 25
basic electric elements (20) 20
devices using stimulated emission (20) 20
chemistry (19) 19
metallurgy (18) 18
index medicus (14) 14
flexible materials not otherwise provided for (13) 13
laundering (13) 13
microbiology (13) 13
paper (13) 13
textiles (13) 13
treatment of textiles or the like (13) 13
biochemistry (12) 12
dyeing leather, furs, or solid macromolecular substances inany form (12) 12
dyeing or printing textiles (12) 12
beer (11) 11
compositions thereof (11) 11
culture media (11) 11
enzymology (11) 11
microorganisms or enzymes (11) 11
mutation or genetic engineering (11) 11
physics (11) 11
propagating, preserving or maintaining microorganisms (11) 11
spirits (11) 11
vinegar (11) 11
wine (11) 11
nanoparticles (10) 10
chemotherapy (8) 8
humans (8) 8
cancer therapies (7) 7
measuring (7) 7
oncology (7) 7
testing (7) 7
cancer (6) 6
drug delivery systems (6) 6
health aspects (6) 6
analysis (5) 5
animals (5) 5
care and treatment (5) 5
conversion or distribution of electric power (5) 5
efficacy (5) 5
female (5) 5
generation (5) 5
lung cancer (5) 5
metastasis (5) 5
nanoscience & nanotechnology (5) 5
organic chemistry (5) 5
original research (5) 5
performing operations (5) 5
research (5) 5
separation (5) 5
transporting (5) 5
acyclic or carbocyclic compounds (4) 4
boards, substations, or switching arrangements for the supplyor distribution of electric power (4) 4
carcinoma (4) 4
cell line, tumor (4) 4
drugs (4) 4
genetic aspects (4) 4
hospitals (4) 4
kinases (4) 4
male (4) 4
medicine (4) 4
methods (4) 4
mice (4) 4
patients (4) 4
physical or chemical processes or apparatus in general (4) 4
technology, industry, and agriculture (4) 4
tumors (4) 4
antigens (3) 3
antineoplastic agents - therapeutic use (3) 3
breast-cancer (3) 3
cells (3) 3
chemical or physical processes, e.g. catalysis or colloidchemistry (3) 3
deoxyribonucleic acid--dna (3) 3
fixed constructions (3) 3
gene expression (3) 3
glycoprotein (3) 3
immune response (3) 3
in-vitro (3) 3
materials science, multidisciplinary (3) 3
medical colleges (3) 3
medical prognosis (3) 3
nanoparticles - chemistry (3) 3
paclitaxel (3) 3
patient outcomes (3) 3
pharmacology & pharmacy (3) 3
radiotherapy (3) 3
respiratory system (3) 3
salinomycin (3) 3
silk (3) 3
silk fibroin (3) 3
stem cells (3) 3
stomach cancer (3) 3
their relevant apparatus (3) 3
therapeutics (3) 3
usage (3) 3
vehicles (3) 3
adult (2) 2
aged (2) 2
anti-tumor efficiency (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 10/2019, Volume 23, Issue 10, pp. 6812 - 6821
Osimertinib is designed to target the secondary resistant EGFR T790M mutant and has shown outstanding clinical efficacy. However, the prognostic prediction of... 
non‐small‐cell lung cancer | circulating tumour DNA | resistance | osimertinib | Adenocarcinoma | Plasma | Epidermal growth factor receptors | p53 Protein | Lung cancer | Non-small cell lung carcinoma | Kinases | Cancer therapies | Patients | Subgroups | Studies | Survival analysis | Heterogeneity | Chemotherapy | Biopsy | Predictions | Biomarkers | Ligands | Mutation | Deoxyribonucleic acid--DNA | Tumors | Original
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 01/2018, Volume 44, Issue 6, pp. 2158 - 2173
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e69643
Aims: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However,... 
MATRIX METALLOPROTEINASES | METASTASIS | EFFICACY | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | CONJUGATE | INHIBITORS | MMP-9 | EXPRESSION | CARCINOMA | CANCER-THERAPY | Taxoids - chemistry | Cell Line | Nanoparticles - chemistry | Peptides - chemistry | Gelatinases - chemistry | Humans | Nanoparticles - ultrastructure | Antineoplastic Agents - administration & dosage | Antineoplastic Agents - chemistry | Nanoparticles - toxicity | Drug Carriers - chemistry | Drug Delivery Systems | Particle Size | Taxoids - administration & dosage | Nuclear Magnetic Resonance, Biomolecular | Polymers - chemistry | Aged | Drugs | Nanoparticles | Atomic force microscopy | Usage | Drug delivery systems | Lung cancer | Docetaxel | Metastasis | Precipitation (Meteorology) | Vehicles | Peptides | Laboratories | Toxicity | Chemical engineering | Clinical trials | Cytotoxicity | Drug delivery | Copolymerization | Matrix metalloproteinase | Kinases | Cancer therapies | Medical schools | Metastases | Anticancer properties | Liver cancer | Video compression | Metalloproteinase | Polymers | Chemical synthesis | Taxotere | Medical research | Quantum dots | Gelatinase | Electron microscopy | MPEG encoders | Gelatinase A | Studies | Chemistry | Transmission electron microscopy | Medical prognosis | Collagen | Antitumor activity | Cancer | Pharmaceuticals | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e88183
Heat shock proteins (HSPs) display adjuvant functions when given as fusion proteins to enhance vaccination efficiency. To evaluate enhanced potency of Hantaan... 
NEUTRALIZING ANTIBODY-RESPONSE | DNA VACCINE POTENCY | HEAT-SHOCK PROTEINS | IN-VITRO | PROTECTIVE IMMUNITY | HEMORRHAGIC-FEVER | C57BL/6 MICE | MULTIDISCIPLINARY SCIENCES | PUUMALA VIRUS | MONOCLONAL-ANTIBODIES | HANTAVIRUS NUCLEOCAPSID PROTEIN | Recombinant Fusion Proteins - immunology | Immunity, Humoral - immunology | Viral Proteins - immunology | Male | Vaccination - methods | Gene Fusion - immunology | Adenoviridae - genetics | Female | Adenoviridae - immunology | Glycoproteins - genetics | Antibody Formation - immunology | Immunity, Cellular - genetics | Genetic Vectors - immunology | HSP70 Heat-Shock Proteins - immunology | Immunity, Humoral - genetics | Mice, Inbred C57BL | Hantaan virus - immunology | Rats | Viral Proteins - genetics | HSP70 Heat-Shock Proteins - genetics | Rats, Sprague-Dawley | Genetic Vectors - genetics | Gene Fusion - genetics | Hantaan virus - genetics | Immunity, Cellular - immunology | Glycoproteins - immunology | Animals | Nucleocapsid Proteins - genetics | Recombinant Fusion Proteins - genetics | Antibodies, Viral - immunology | Nucleocapsid Proteins - immunology | Mice | Viral Vaccines - immunology | Animal experimentation | Immune response | Wildlife conservation | Vaccination | Genes | Heat shock proteins | Proteins | Adenoviruses | Genetically modified organisms | Genetic aspects | Genetic engineering | Health aspects | Laboratories | Viruses | Infections | Vaccines | Immunology | Rodents | Deoxyribonucleic acid--DNA | Recombinant | Expression vectors | Immune system | Antigens | Immunization | Glycoprotein | Hsp70 protein | RNA polymerase | Gene expression | Gene fusion | Immune response (humoral) | Immunogenicity | Hemorrhagic fever with renal syndrome | Viral infections | Heat shock | Deoxyribonucleic acid | DNA
Journal Article
by Tian, PY and Wang, YQ and Liu, H and Yang, YL and Wu, XL and Wei, H and Chen, TT
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, ISSN 2235-2988, 07/2019, Volume 9, p. 275
Respiratory syncytial virus (RSV) is the major cause of pulmonary and bronchial inflammation in infants, young children, and immunocompromised adults, but... 
INFECTIONS | PROTEIN | VACCINE | phage display technology | MICROBIOLOGY | IMMUNOLOGY | LIVE-ATTENUATED SALMONELLA | B-CELLS | PATHOGENESIS | inflammation | RT-PCR | LIPOPOLYSACCHARIDE | respiratory syncytial virus (RSV) | signal pathway | GLYCOPROTEIN | monoclonal antibody | Monoclonal antibodies | Inflammation | Infants | Research | Health aspects | Analysis
Journal Article
Targeted Oncology, ISSN 1776-2596, 4/2019, Volume 14, Issue 2, pp. 159 - 168
Journal Article
Journal Article
Journal Article
Journal of Biomaterials Applications, ISSN 0885-3282, 11/2018, Volume 33, Issue 5, pp. 707 - 724
Paclitaxel is widely used as a radiosensitizer for various tumors, including esophageal cancer, but its therapeutic effect remains to be improved. In this... 
red blood cell membrane | paclitaxel | Radiosensitizer | esophageal cancer | nanoparticles | epidermal growth factor receptor | SURGERY | STEM-CELLS | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | MECHANISMS | DELIVERY | GROWTH-FACTOR RECEPTOR | OVEREXPRESSION | DRUG PENETRATION | AMPLIFICATION | NEOADJUVANT CHEMORADIOTHERAPY | 3D MULTICELLULAR SPHEROIDS
Journal Article